EDGAR Filing Documents for 0001012975-24-000204

Form 13F-HR - Quarterly report filed by institutional managers, Holdings:

SEC Accession No. 0001012975-24-000204

Filing Date

2024-05-14

Accepted

2024-05-14 16:07:50

Documents

Period of Report

2024-03-31

Effectiveness Date

2024-05-14

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	13F-HR
1		primary_doc.xml	13F-HR	2414
2	INFORMATION TABLE	infotable.html	INFORMATION TABLE
2	INFORMATION TABLE	infotable.xml	INFORMATION TABLE	6483
	Complete submission text file	0001012975-24-000204.txt		10122

Mailing Address 501 2ND ST, SUITE 200 SAN FRANCISCO CA 94107

Business Address 501 2ND ST, SUITE 200 SAN FRANCISCO CA 94107 415-948-7474

Pivotal bioVenture Partners Investment Advisor LLC (Filer) CIK: 0001844645 (see all company filings)

IRS No.: 814749159 | State of Incorp.: DE
Type: 13F-HR | Act: 34 | File No.: 028-20630 | Film No.: 24944335